Stocks and InvestingStocks and Investing
Mon, January 22, 2024
Fri, January 19, 2024
Thu, January 18, 2024

Matthew Sykes Maintained (TWST) at Strong Buy with Increased Target to $45 on, Jan 18th, 2024


Published on 2024-10-28 08:25:23 - WOPRAI, Matthew Sykes
  Print publication without navigation


Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Strong Buy with Increased Target from $25 to $45 on, Jan 18th, 2024.

Matthew has made no other calls on TWST in the last 4 months.



There is 1 other peer that has a rating on TWST. Out of the 1 peers that are also analyzing TWST, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Gaurav Goparaju of "Berenberg" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 27th, 2023